The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $714,453 in first-year total cost, median $240,832.
Most frequent study sections
- Special Emphasis Panel[ZCA1 SRB-F (M2)]3
Most frequent institutions
- BRIGHAM AND WOMEN'S HOSPITAL1
- EMORY UNIVERSITY1
- MAKERERE UNIVERSITY WALTER REED PROJECT1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Botswana CASCADE Clinical Trials Site1UG1CA275416-01 | DRYDEN-PETERSON, SCOTTRAMOGOLA-MASIRE, DOREEN | BRIGHAM AND WOMEN'S HOSPITAL, MA | $257,815 | ZCA1 |
| 2022 | HIV/cervical cancer cOntrol and Prevention clinical sitE in Kenya (HOPE-Kenya)1UG1CA275400-01 | CHUNG, MICHAEL HOONBAESAKR, SAMAH RAFIE | EMORY UNIVERSITY, GA | $240,832 | ZCA1 |
| 2022 | Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Uganda (CASCADE UGANDA)1UG1CA275412-01 | MWESIGWA, BETTY | MAKERERE UNIVERSITY WALTER REED PROJECT | $215,806 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.